A comparison of adeB gene expression levels under conditions of induced resistance by different drugs in vitro in Acinetobacter baumannii

Zhu,Wan; Wang,Hui; Zhang,Jing‑Ping

doi:10.3892/etm.2017.4242

A comparison of adeB gene expression levels under conditions of induced resistance by different drugs in vitro in Acinetobacter baumannii

Authors:
- Wan Zhu
- Hui Wang
- Jing‑Ping Zhang
View Affiliations

Affiliations: Department of Nosocomial Infection Control, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Division of Infectious Diseases, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: March 20, 2017 https://doi.org/10.3892/etm.2017.4242
Pages: 2177-2182
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study was designed to analyze the difference of the adeB gene expression levels under conditions of induced resistance and to verify the significance of the AdeABC efflux pump in the in vitro induction of Acinetobacter baumannii (A. baumannii). Strains were isolated from blood or drainage samples in the First Hospital of China Medical University. The minimum inhibitory concentration (MIC) was determined by a broth microdilution method. In addition, an in vitro induction of drug‑resistance tests was confirmed with the three drugs. The expression level of the adeB was determined by quantitative polymerase chain reaction (qPCR), and there were 19, 17 and 25 strains isolated from this test that were susceptible to amikacin, netilmicin and imipenem, respectively. Furthermore, 11, 15 and 8 stably resistant strains generated against amikacin, netilmicin and imipenem, respectively, by in vitro induction. The MIC values of all the imipenem‑sensitive and imipenem‑resistant strains decreased by no more than 2‑fold under carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-containing conditions. The MIC values of 10 amikacin‑resistant and 14 netilmicin-resistant strains decreased 4‑fold or more under CCCP‑containing conditions. Furthermore, qPCR revealed that none of the imipenem‑sensitive or the imipenem‑resistant strains expressed the adeB gene, but there were 10 amikacin-resistant and 5 netilmicin‑resistant strains that expressed the adeB gene. In conclusion, the present study confirmed that in vitro induction of drug‑resistance tests in sensitive A. baumannii strains could produce drug‑resistance following long‑term exposure to low doses of antibacterial drugs. In addition, amikacin and netilmicin are more prone to producing drug‑resistance compared to imipenem in vitro. The results of the efflux phenotype indicate the possible application of CCCP in the inhibition of the efflux system in some drugs. The inconsistency between efflux phenotype and qPCR of adeB indicates that other mechanisms may also be included in the induction of drug‑resistance that work with the active mechanism in order to increase drug resistance to common clinically‑used antimicrobial drugs.

View Figures

View References

1	Bergogne-Bérézin E and Towner KJ: Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 9:148–165. 1996.PubMed/NCBI
2	Guardado Rodríguez A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, et al: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: Assessment of different treatments. J Antimicrob Chemother. 61:908–913. 2008. View Article : Google Scholar : PubMed/NCBI
3	Magnet S, Courvalin P and Lambert T: Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 45:3375–3380. 2001. View Article : Google Scholar : PubMed/NCBI
4	Peleg AY, Adams J and Paterson DL: Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother. 51:2065–2069. 2007. View Article : Google Scholar : PubMed/NCBI
5	Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational SupplementCLSI documen M100-S22. CLSI; Wayne, PA: 2012
6	Shi WF, Jiang JP, Xu N, Huang ZM and Wang YY: Inhibitory effects of reserpine and carbonyl cyanide m-chloro-phenylhydrazone on fluoroquinolone resistance of Acinetobacter baumannii. Chin Med J (Engl). 118:340–343. 2005.PubMed/NCBI
7	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
8	Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M, Tomasone F, Amato G, Brisse S, Triassi M, Utili R and Zarrilli R: Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol. 48:1223–1230. 2010. View Article : Google Scholar : PubMed/NCBI
9	Fernandez-Cuenca F, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ and Pascual A: Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 51:565–574. 2003. View Article : Google Scholar : PubMed/NCBI
10	Lee JK, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ and Pascual A: Mutations in the gyrA and gyrC genes in ciprofloxacin-resistant clinical isolates of Acinetobacter baumannii in Korea. Microbiol Immunol. 49:647–653. 2005. View Article : Google Scholar : PubMed/NCBI
11	Yoon EJ, Courvalin P and Grillot-Courvalin C: RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: Major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother. 57:2989–2995. 2013. View Article : Google Scholar : PubMed/NCBI
12	Rajamohan G, Srinivasan VB and Gebreyes WA: Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii. J Antimicrob Chemother. 65:1919–1925. 2010. View Article : Google Scholar : PubMed/NCBI
13	Ni W, Li Y, Guan J, Zhao J, Cui J, Wang R and Liu Y: Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria. Antimicrob Agents Chemother. 60:3215–3218. 2016. View Article : Google Scholar : PubMed/NCBI
14	Principe L, D'Arezzo S, Capone A, Petrosillo N and Visca P: In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob. 8:182009. View Article : Google Scholar : PubMed/NCBI
15	Ruzin A, Keeney D and Bradford PA: AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother. 59:1001–1004. 2007. View Article : Google Scholar : PubMed/NCBI
16	Lin L, Ling BD and Li XZ: Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int J Antimicrob Agents. 33:27–32. 2009. View Article : Google Scholar : PubMed/NCBI
17	Poole K: Outer membranes and efflux: The path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol. 3:77–98. 2002. View Article : Google Scholar : PubMed/NCBI
18	Zhang JP, Zhu W, Tian SF, Chu YZ and Chen BY: Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China. J Microbiol. 48:689–694. 2010. View Article : Google Scholar : PubMed/NCBI
19	Heritier C, Poirel L, Lambert T and Nordmann P: Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 49:3198–3202. 2005. View Article : Google Scholar : PubMed/NCBI
20	Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP and Lin JF: An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob Agents Chemother. 51:3844–3852. 2007. View Article : Google Scholar : PubMed/NCBI
21	Rhomberg PR and Jones RN: MYSTIC Program (USA) Study Group: Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: Report from the MYSTIC program (2002) in North America. Diagn Microbiol Infect Dis. 47:365–372. 2003. View Article : Google Scholar : PubMed/NCBI